ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,892Medicare Part D Prescriptions Filled, Including Refills

Rank: 117 out of 2604

$609K Total Retail Price of All Prescriptions

Rank: 114 out of 2604

876 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 876 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

15% of this provider’s 876 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 7,490 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 582 462 1 2
LISINOPRIL 449 363 2 3
LEVOTHYROXINE SODIUM 394 320 3 4
OMEPRAZOLE 370 280 4 5
HYDROCODONE-ACETAMINOPHEN 277 193 S3 5 1
METFORMIN HCL 257 161 6 7
AMLODIPINE BESYLATE 253 242 7 6
METOPROLOL SUCCINATE 223 213 8 17
FUROSEMIDE 214 154 9 8
METOPROLOL TARTRATE 200 167 10 9
HYDROCHLOROTHIAZIDE 193 175 11 10
ALENDRONATE SODIUM 154 119 12 29
ATENOLOL 134 96 13 11
LOVASTATIN 112 101 14 24
POTASSIUM CHLORIDE 112 94 14 16
SERTRALINE HCL 111 77 16 23
FENOFIBRATE 106 78 17 69
WARFARIN SODIUM 97 70 18 13
GABAPENTIN 90 78 19 12
DIGOXIN 88 64 20 71
RANITIDINE HCL 88 67 20 25
CITALOPRAM HBR 82 70 22 18
CARVEDILOL 82 60 22 26
NIASPAN 74 48 24 170
SPIRIVA 73 47 25 45
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 63 26 22
GLYBURIDE 70 60 R 27 83
MELOXICAM 69 61 28 36
TRIAMTERENE-HCTZ 69 67 28 55
PLAVIX 69 65 28 75
GLIMEPIRIDE 69 60 28 57
TAMSULOSIN HCL 68 68 32 30
CLOPIDOGREL 65 53 33 39
MORPHINE SULFATE ER 65 30 S2 33 58
LANTUS 64 51 35 40
KLOR-CON M20 63 48 36 86
ALLOPURINOL 61 49 37 35
GLIPIZIDE 59 40 38 51
LOSARTAN POTASSIUM 58 56 39 20
ATORVASTATIN CALCIUM 58 44 39 19
TRAZODONE HCL 57 20 41 46
PREDNISONE 56 47 42 34
TRAMADOL HCL 56 39 42 15
FLUOXETINE HCL 54 35 44 49
LANTUS SOLOSTAR 54 47 44 84
ESCITALOPRAM OXALATE 53 47 46 73
ACTOS 53 41 46 116
AZITHROMYCIN 53 37 46 33
FLUTICASONE PROPIONATE 52 23 49 31
DONEPEZIL HCL 52 52 49 28
OXYCONTIN 52 0 S2 49 128
ACETAMINOPHEN-CODEINE 51 36 S3 52 60
CYMBALTA 50 34 53 44
PRAVASTATIN SODIUM 50 38 53 14
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.